YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly records better-than-expected Q2 results

Posted online

Eli Lilly had better-than-expected results in the second quarter amid higher sales of Zepbound and Mounjaro.

Adjusted earnings per share were $3.92. Analysts expected $2.60 per share.

Revenue was reported at $11.3 billion. Analysts were looking for $9.9 billion.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences